Clinical Trial Update: Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effects of riboflavin on Faecalibacterium prausnitzii and the gut microbiota has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gut Microbiota-related Disorders

Drugs mentioned

• Riboflavin (riboflavin)

Snippet

Sponsor: dsm-firmenich Switzerland AG | Conditions: Gut Microbiota | Phase 2 | Status: COMPLETED